Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1

Molecular Pharmacology

Volumn 66, Issue 3, 2004, Pages 387-394

  Hartz, Anika M S ^a,b   Bauer, Björn ^a   Fricker, Gert ^b   Miller, David S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; GLYCOPROTEIN P; NITROPRUSSIDE SODIUM; PHORBOL ESTER; PROTEIN KINASE C ACTIVATOR; SARAFOTOXIN; SARAFOTOXIN S6C; VALSPODAR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CAPILLARIES; ENDOTHELIN-1; MALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 4944230261     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.001503     Document Type: Article

References (32)

1. Brooks DP, Jorkasky DK, Freed MI, and Ohlstein EH (1998) Pathophysiological role of endothelin and potential therapeutic targets for receptor antagonists, in Endothelin- Molecular Biology, Physiology and Pathology (Highsmith RF ed) pp 223-268, Humana Press, Totowa.
2. Chen WS, Luker KE, Dahlheimer JL, Pica CM, Luker GD, and Piwnica-Worms D (2000) Effects of MDR1 and MDR3 P-glycoproteins, MRP1 and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin. Biochem Pharmacol 60:413-426.
3. Cisternino S, Mercier C, Bourasset F, Roux F, and Scherrmann JM (2004) Expression, up-regulation and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res 64:3296-3301.
4. Cooray HC, Blackmore CG, Maskell L, and Barrand MA (2002) Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13:2059-2063.
5. Demeuse P, Fragner P, Leroy-Noury C, Mercier C, Payen L, Fardel O, Couraud PO, and Roux F (2004) Puromycin selectively increases mdrla expression in immortalized rat brain endothelial cell lines. J Neurochem 88:23-31.
6. Didier N, Banks WA, Creminon C, Dereuddre-Bosquet N, and Mabondzo A (2002) HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier. Neuroreport 13:1179-1183.
7. Eisenblatter T and Galla HJ (2002) A new multidrug resistance protein at the blood-brain barrier. Biochem Biophys Res Commun 293:1273-1278.
8. Erdlenbruch B, Alipour M, Fricker G, Miller DS, Kugler W, Eibl H, and Lakomek M (2003) Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries. Br J Pharmacol 140:1201-1210.
9. Fellner S, Bauer B, Miller DS, Schaffrik M, Fankhanel M, Spruss T, Bernhardt G, Graeff C, Farber L, Gschaidmeier H, et al. (2002) Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Investig 110:1309-1318.
10. Goralski KB, Hartmann G, Piquette-Miller M, and Renton KW (2003) Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol 139:35-48.
11. Hughes PM, Anthony DC, Ruddin M, Botham MS, Rankine EL, Sablone M, Baumann D, Mir AK, and Perry VH (2003) Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol 62:1276-1286.
12. Kedzierski RM and Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41:851-876.
13. Kipp H and Arias IM (2002) Trafficking of canalicular ABC transporters in hepatocytes. Annu Rev Physiol 64:595-608.
14. Kroll RA and Neuwelt EA (1998) Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42:1083-1100.
15. Levin ER (1995) Endothelins. N Engl J Med 333:356-363.
16. Masereeuw R, Terlouw SA, van Aubel RA, Russel FG, and Miller DS (2000) Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule. Mol Pharmacol 57:59-67.
17. Miller DS (2002) Xenobiotic export pumps, endothelin signaling and tubular nephrotoxicants - a case of molecular hijacking. J Biochem Mol Toxicol 16:121-127.
18. Miller DS (2003) Confocal imaging of xenobiotic transport across the blood-brain barrier. J Exp Zoolog Part A Comp Exp Biol 300:84-90.
19. Miller DS, Graeff C, Droulle L, Flicker S, and Flicker G (2002) Xenobiotic efflux pumps in isolated fish brain capillaries. Am J Physiol 282:R191-R198.
20. Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, and Flicker G (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol 58:1357-1367.
21. Miller DS, Sussman CR, and Renfro JL (1998) Protein kinase C regulation of p-glycoprotein-mediated xenobiotic secretion in renal proximal tubule. Am J Physiol 275:F785-F795.
22. Narushima I, Kita T, Kubo K, Yonetani Y, Momochi C, Yoshikawa I, Shimada K, and Nakashima T (1999) Contribution of endothelin-1 to disruption of blood-brain barrier permeability in dogs. Naunyn Schmiedeberg's Arch Pharmacol 360:639-645.
23. Narushima I, Kita T, Kubo K, Yonetani Y, Momochi C, Yoshikawa I, Ohno N, and Nakashima T (2003) Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats. Pharmacol Toxicol 92:21-26.
24. Nie XJ and Olsson Y (1996) Endothelin peptides in brain diseases. Rev Neurosci 7:177-186.
25. Notenboom S, Miller DS, Smits P, Russel FG, and Masereeuw R (2002) Role of NO in endothelin-regulated drug transport in the renal proximal tubule. Am J Physiol 282:F458-F464.
26. Notenboom S, Miller DS, Smits P, Russel FG, and Masereeuw R (2004) Involvement of guanylyl cyclase and cGMP in the regulation of Mrp2-mediated transport in the proximal tubule. Am J Physiol 287:F33-F38.
27. 2-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier. J Neurochem 87:1043-1051.
28. Schinkel AH (1999) P-glycoprotein, a gatekeeper in the blood-brain barrier. Ado Drug Deliv Rev 36:179-194.
29. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. (1994) Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
30. Schinkel AH, Wagenaar E, Mol CA, and van Deemter L (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Investig 97:2517-2524.
31. Schramm U, Flicker G, Wenger R, and Miller DS (1995) P-glycoprotein- mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am J Physiol 268:F46-F52.
32. Terlouw SA, Masereeuw R, Russel FG, and Miller DS (2001) Nephrotoxicants induce endothelin release and signaling in renal proximal tubules: effect on drug efflux. Mol Pharmacol 59:1433-1440.